Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ina Oehme

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Cells|April 28, 2015
HDAC Family Members Intertwined in the Regulation of Autophagy: A Druggable Vulnerability in Aggressive Tumor EntitiesEmily Koeneke, Olaf Witt, Ina Oehme
European Journal of Immunology|March 12, 2005
Transgenic overexpression of the Caspase-8 inhibitor FLIP(short) leads to impaired T cell proliferation and an increased memory T cell pool after staphylococcal enterotoxin B injectionIna Oehme, Frank Neumann, Susanne Bösser, et al.
Autophagy|October 23, 2013
Histone deacetylase 10-promoted autophagy as a druggable point of interference to improve the treatment response of advanced neuroblastomasIna Oehme, Marco Lodrini, Nathan R Brady, et al.
Cancer Letters|October 1, 2008
HDAC family: What are the cancer relevant targets?Olaf Witt, Hedwig E Deubzer, Till Milde, et al.
Seminars in Cancer Biology|February 14, 2026
Intratumor Heterogeneity and Clonal Evolution in Sarcomas: Molecular, Cellular, and Functional Drivers of Therapy ResistanceThomas G P Grünewald, Ina Oehme, Johanna Wagner, et al.
Expert Opinion on Investigational Drugs|September 29, 2009
Targeting of HDAC8 and investigational inhibitors in neuroblastomaIna Oehme, Hedwig E Deubzer, Marco Lodrini, et al.
Frontiers in Oncology|December 24, 2024
Neuroblastoma response to RAS-MAPK inhibitors and APR-246 (eprenetapopt) co-treatment is dependent on SLC7A11Vid Mlakar, Ina Oehme, Laurence Lesne, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2022
Evaluation of Antitumor and On-Target Activity of HDAC Inhibitors with the Zebrafish Embryo Xenograft ModelCharlotte Gatzweiler, Johannes Ridinger, Simay Ayhan, et al.
Anti-Cancer Drugs|September 4, 2008
HKI 46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cellsDennis Wegener, Hedwig E Deubzer, Ina Oehme, et al.
IEEE Transactions on Medical Imaging|September 13, 2022
Patient-by-Patient Deep Transfer Learning for Drug-Response Profiling Using Confocal Fluorescence Microscopy of Pediatric Patient-Derived Tumor-Cell SpheroidsYannick Berker, Dina ElHarouni, Heike Peterziel, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Cells|April 28, 2015
HDAC Family Members Intertwined in the Regulation of Autophagy: A Druggable Vulnerability in Aggressive Tumor EntitiesEmily Koeneke, Olaf Witt, Ina Oehme
European Journal of Immunology|March 12, 2005
Transgenic overexpression of the Caspase-8 inhibitor FLIP(short) leads to impaired T cell proliferation and an increased memory T cell pool after staphylococcal enterotoxin B injectionIna Oehme, Frank Neumann, Susanne Bösser, et al.
Autophagy|October 23, 2013
Histone deacetylase 10-promoted autophagy as a druggable point of interference to improve the treatment response of advanced neuroblastomasIna Oehme, Marco Lodrini, Nathan R Brady, et al.
Cancer Letters|October 1, 2008
HDAC family: What are the cancer relevant targets?Olaf Witt, Hedwig E Deubzer, Till Milde, et al.
Seminars in Cancer Biology|February 14, 2026
Intratumor Heterogeneity and Clonal Evolution in Sarcomas: Molecular, Cellular, and Functional Drivers of Therapy ResistanceThomas G P Grünewald, Ina Oehme, Johanna Wagner, et al.
Expert Opinion on Investigational Drugs|September 29, 2009
Targeting of HDAC8 and investigational inhibitors in neuroblastomaIna Oehme, Hedwig E Deubzer, Marco Lodrini, et al.
Frontiers in Oncology|December 24, 2024
Neuroblastoma response to RAS-MAPK inhibitors and APR-246 (eprenetapopt) co-treatment is dependent on SLC7A11Vid Mlakar, Ina Oehme, Laurence Lesne, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2022
Evaluation of Antitumor and On-Target Activity of HDAC Inhibitors with the Zebrafish Embryo Xenograft ModelCharlotte Gatzweiler, Johannes Ridinger, Simay Ayhan, et al.
Anti-Cancer Drugs|September 4, 2008
HKI 46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cellsDennis Wegener, Hedwig E Deubzer, Ina Oehme, et al.
IEEE Transactions on Medical Imaging|September 13, 2022
Patient-by-Patient Deep Transfer Learning for Drug-Response Profiling Using Confocal Fluorescence Microscopy of Pediatric Patient-Derived Tumor-Cell SpheroidsYannick Berker, Dina ElHarouni, Heike Peterziel, et al.
Pageof 9